Back to results
US 8,007,794 B2Granted
Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
AssigneeRinat Neuroscience Corp.
InventorsJoerg Zeller, Kristian T. Poulsen, Yasmina Noubia Abdiche, Jaume Pons, Sierra Leigh Jones Collier, Arnon Rosenthal
Life of this patent
Estimating the term…
Abstract
The invention features methods for preventing or treating CGRP associated disorders such as vasomotor symptoms, including headaches (e.g., migraine, cluster headache, and tension headache) and hot flushes, by administering an anti-CGRP antagonist antibody. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Claims9
An isolated antibody comprising
- a. CDR H1 as set forth in SEQ ID NO:
- 3:
- b. CDR H2 as set forth in SEQ ID NO:
- 4, or variants as shown in Table 6;
- c. CDR H3 as set forth in SEQ ID NO:
- 5:
- d. CDR L1 as set forth in SEQ ID NO:
- 6, or variants as shown in Table 6;
- e. CDR L2 as set forth in SEQ ID NO:
- 7, or variants as shown in Table 6;
- and
- f. CDR L3 as set forth in SEQ ID NO:
- 8;
- wherein the antibody has a binding affinity (KD) to human α-CGRP of 50 nM or less as measured by surface plasmon resonance at 37° C.
11 more elements
An isolated antibody comprising a VH domain comprising SEQ ID NO:
- 1 and a VL domain comprising SEQ ID NO:
- 2.
Dependencies are inferred from the claim text.